Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Ondine Biomedical Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2029 | $268.30M | $268.30M - $268.30M | -$268.30M | $0.109 | 1 |
| Dec 2028 | $102.20M | $102.20M - $102.20M | -$102.20M | $0.02 | 1 |
| Dec 2027 | $34.93M | $34.93M - $34.93M | -$34.93M | -$0.01 | 1 |
| Dec 2026 | $12.11M | $12.11M - $12.11M | -$12.11M | -$0.04 | 1 |
| Dec 2025 | $4.89M | $4.89M - $4.89M | -$4.89M | -$0.06 | 1 |
| Dec 2024 | $2.80M | $2.80M - $2.80M | -$2.80M | -$0.06 | 1 |
| Dec 2023 | $1.39M | $1.39M - $1.39M | -$1.39M | -$0.066 | 1 |
| Dec 2022 | $587.9K | $587.9K - $587.9K | -$587.9K | -$0.096 | 1 |
| Dec 2021 | $3.28M | $3.28M - $3.28M | -$3.28M | -$0.201 | 1 |